Journal of Pain and Symptom Management
Volume 36, Issue 5 , Pages 461-467 , November 2008

Treatment Efficacy of Neural Blockade in Specialized Palliative Care Services in Japan: A Multicenter Audit Survey

  • Yo Tei, MD

      Affiliations

    • Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu
    • ,
  • Tatsuya Morita, MD

      Affiliations

    • Department of Palliative and Supportive Care, Palliative Care Team and Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu
    • Corresponding Author InformationAddress correspondence to: Tatsuya Morita, MD, Department of Palliative and Supportive Care, Palliative Care Team and Seirei Hospice, Seirei Mikatahara General Hospital, 3453 Mikatabara-cho, Hamamatsu, Shizuoka 433-8558, Japan.
    • ,
  • Toshimichi Nakaho, MD

      Affiliations

    • Department of Palliative Medicine, Tohoku University Hospital, Miyagi
    • ,
  • Chizuko Takigawa, MD

      Affiliations

    • Department of Palliative Medicine, Keiyukai Sapporo Hospital, Sapporo
    • ,
  • Akiko Higuchi, MD

      Affiliations

    • Division of Anesthesiology and Palliative Care Unit, Toyama Prefectural Central Hospital, Toyama
    • ,
  • Akihiko Suga, MD

      Affiliations

    • Department of Palliative Medicine, Shizuoka General Hospital, Shizuoka
    • ,
  • Tsukasa Tajima, MD

      Affiliations

    • Department of Palliative Medicine, Miyagi Cancer Center, Miyagi
    • ,
  • Masayuki Ikenaga, MD

      Affiliations

    • Hospice, Yodogawa Christian Hospital, Osaka
    • ,
  • Hitomi Higuchi, MD

      Affiliations

    • Palliative Care Center, Showa University Hospital, Tokyo
    • ,
  • Naohito Shimoyama, MD, PhD

      Affiliations

    • Department of Palliative Medicine, National Cancer Center Hospital, Tokyo
    • ,
  • Mayumi Fujimoto, MD

      Affiliations

    • Department of Anesthesiology, Hiroshima Prefectural Hospital, Hiroshima, Japan

,Accepted 23 November 2007.

References 

  1. Ventafridda V, Tamburini M, Caraceni A, de Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59:850–856
  2. Hagan Q, Haddox JD, Abram S, et al. Epidural opiates and local anaesthetic for the management of cancer pain. Pain. 1991;46:271–279
  3. Zech DFJ, Grond S, Lynch J, Hertel D, Lehman KA. Validation of World Health Organisation guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63:65–76
  4. Grond S, Zech D, Schug SA, Lynch J, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage. 1991;6:411–422
  5. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg. 1995;80:290–295
  6. de Oliveira R, dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain. 2004;110:400–408
  7. Wong GY, Schroeder DR, Carns PE, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable. Pancreatic cancer. JAMA. 2004;291:1092–1099
  8. Mercadante S. Celiac plexus block versus analgesics in pancreatic cancer pain. Pain. 1993;52:187–192
  9. Kawamata M, Ishitani K, Ishikawa K, et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain. 1996;64:597–602
  10. Mercadante S, Catala E, Arcuri E, Casuccio A. Celiac plexus block for pancreatic cancer pain: factors influencing pain. Symptoms and quality of life. J Pain Symptom Manage. 2003;26:1140–1147
  11. Slatkin NE, Rhiner M. Phenol saddle blocks for intractable pain at end of life: report of four cases and literature review. Am J Hosp Palliat Care. 2003;20:62–66
  12. Hassenbusch SJ, Portenoy RK, Cousins M, et al. Polyanalgesic consensus conference 2003: an update on the management of pain by intraspinal drug delivery-report of an expert panel. J Pain Symptom Manage. 2004;27:540–563
  13. Baker L, Lee M, Regnard C, Crack L, Callin S. Evolving spinal analgesia practice in palliative care. Palliat Med. 2004;18:507–515
  14. Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040–4049
  15. Smith TJ, Coyne P. Implantable drug delivery systems (IDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients. J Palliat Med. 2005;8:736–742
  16. Miyashita M, Matoba K, Sasahara T, et al. Reliability and validity of the Japanese version of the Support Team Assessment Schedule (STAS-J). Palliat Support Care. 2004;2:379–385
  17. Morita T, Tusnoda J, Inoue S, Chihara S, Oka K. Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study. Palliat Med. 2001;15:197–206
  18. Morita T, Tei Y, Inoue S. Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliat Med. 2003;6:557–563
  19. Morita T, Hyodo I, Yoshimi T, et al. Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol. 2005;16:640–647
  20. Hanks GCW, Cherny N. Opioid analgesic therapy. In:  Doyle D,  Hanks GCW,  MacDonald N editor. Oxford textbook of palliative medicine. 2nd edn. New York: Oxford Medical Publications; 1998;p. 331–355

PII: S0885-3924(08)00201-7

doi: 10.1016/j.jpainsymman.2007.11.009

Journal of Pain and Symptom Management
Volume 36, Issue 5 , Pages 461-467 , November 2008

Article Tools

* Image Usage & Resolution